PATENT CLAIM ANALYSIS

Application Number: 15863016
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "093700"]

Abstract:
The present invention discloses a method of identifying agents that affect human astrocytes functionality using ex-vivo differentiated pluripotent stem cells (PSC). In addition, the use of human progenitor astrocytes or human astrocytes for the treatment of Amyotrophic Lateral Sclerosis (ALS) in a human subject is also disclosed.

Claim (Index 11):
The method of  claim 10 , wherein said progenitor astrocytes or astrocytes express each of GFAP, GLAST, AQP4 or a combination thereof.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 86.0
- Lexical Diversity: 1.28571
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13324956', '14758185', '11281040', '14701245', '12054245']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7163964851099304
- 35 USC 102 Novelty (BERT): 0.5261795097673923
- Combined Prediction Score: 0.6973747875756766
- Mean Citation Score: 268.100882
- Max Citation Score: 275.51596
- Similarity Product: 157.55496818942547

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test